Javeed Siddiqui, MD, MPH, co-founder and chief medical officer of TeleMed2U, created the IDea Incubator to provide a platform for innovators to share their ideas with the infectious diseases community and potentially receive funding for their project. Dr. Siddiqui shares more about the IDea Incubator and why you should submit your idea.
The IDSA Foundation advances the field of infectious diseases by ensuring the next generation of ID specialists has the resources, funding and support they need to continue their life-saving work. In recognition of our ID heroes and the advancements they have made, we are proud to celebrate a Summer of Science!
Donate before August 31 to double your impact with a dollar-for-dollar match sponsored by the IDSA Foundation’s Industry Partner Program up to $20,000. If your gift is $40 or more, you will also receive a limited-edition Trust Science baseball cap as a token of the Foundation’s appreciation.
Apply Now: 2021 Microbial Pathogenesis in
Alzheimer’s Disease Grant
Do you want to help uncover a potential missing link between an infection and chronic disease that could help unravel the complex origins of Alzheimer’s disease? Apply today for the 2021 Microbial Pathogenesis in Alzheimer’s Disease Grant! This year, we’ve increased the total amount of available grant funding to $1.7 million. Learn more about how you can apply for the opportunity to receive an individual research grant of up to $250,000.
Infectious diseases specialists and all those working diligently alongside them have risen to the challenges of the COVID-19 pandemic and represent a diverse group of all-stars. Eliot Godofsky, MD, FACP, FIDSA, shares a touching story of the heroes he encountered at his practice throughout the pandemic.
Nominate a Pandemic Hero of your own today! Salute the nurses, administrative staff, sanitation workers, researchers and more who have played a vital role in reducing the impacts of the pandemic and supporting the health of all communities. By making a $20 donation in their honor, the Foundation will highlight these heroes and send them a gift as a token of our appreciation.
Applications are now open for the 2021 virtual IDWeek Mentorship Program. Through this program, the IDSA Foundation connects experienced ID researchers and clinicians with medical students and residents and focuses on three key elements: professional development, education and a vision for the mentee’s future career. Apply now for the opportunity to make invaluable connections and create lifelong relationships within the ID community.
Are you caught up on the IDSA Foundation’s latest blogs? From diving into the complex topic of HIV primary care to sitting down with 2020 IDea Incubator past finalists, we are committed to sharing insights from ID specialists across the country and providing the latest IDSA Foundation news.
ID Across Generations: A Father & Son’s Perspective...IDSA Foundation supporter Steven Schnittman, MD, and his son Samuel Schnittman, MD, share their passion for the field of ID and the importance of mentorship and funding opportunities to support the specialty.
The IDSA Foundation’s Industry Partners ensure our work continues for years to come. Thanks to our generous supporters, we can support life-saving research, fund innovative programs and cultivate the next generation of diverse infectious diseases professionals. We’re proud to highlight our Industry Partners to showcase what they do best. This month, we’re putting the spotlight on Merck:
For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.